Health
Pfizer, BioNTech Seek US Emergency OK for COVID-19 Vaccine in Adolescents – Voice of America
Pfizer and its German partner BioNTech asked U.S. regulators Friday to allow the emergency use of their vaccine in adolescents ages 12 to 15. The vaccine is currently…
Pfizer and its German partner BioNTech asked U.S. regulators Friday to allow the emergency use of their vaccine in adolescents ages 12 to 15.
The vaccine is currently authorized for emergency use in the United States for people age 16 and older. The companies said Friday that they requested an expansion of the authorization from the U.S. Food and Drug Administration (FDA) to include the younger age group.
In March, the drugmakers said the vaccine was found to be safe and effective and had produced…
-
General20 hours agoVictorian school teacher charged with soliciting child abuse material
-
General11 hours agoAustralia loses ODI series to South Africa with defeat in second game in Mackay
-
Noosa News15 hours agoPalestine protesters forced into last-minute reroute
-
Business23 hours agoEconomic roundtable or maturity test?